SCHEMBL24545232

SCHEMBL24545232

Clc1ccc2c(c1)oc1ccc3oc(-c4ccccc4)nc3c12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.58
CASP3 P42574 2/20 0.58
SENP7 Q9BQF6 2/20 0.58
SENP6 Q9GZR1 2/20 0.58
AHR P35869 3/20 0.47
RAB9A P51151 5/20 0.43
KDM4E B2RXH2 4/20 0.43
NPC1 O15118 4/20 0.43
NPSR1 Q6W5P4 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTT P42858 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
HPGD P15428 3/20 0.43
NFKB1 P19838 2/20 0.43
NFKB2 Q00653 2/20 0.43
RELA Q04206 2/20 0.43
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24546320 0.90 SMN1; SMN2 (0.60) SMN1; SMN2CASP3SENP7SENP6AHR
SCHEMBL27383292 0.85 SMN1; SMN2 (0.57) SMN1; SMN2CASP3SENP7SENP6RAB9A
SCHEMBL25729949 0.83 SMN1; SMN2 (0.58) SMN1; SMN2CASP3SENP7SENP6RAB9A
SCHEMBL25551820 0.83 SMN1; SMN2 (0.61) SMN1; SMN2CASP3SENP7SENP6RAB9A
SCHEMBL26450534 0.82 ALDH1A1 (0.48) SMN1; SMN2CASP3SENP7SENP6AHR
SCHEMBL25551888 0.81 SMN1; SMN2 (0.63) SMN1; SMN2CASP3SENP7SENP6RAB9A
SCHEMBL24545233 0.81 SMN1; SMN2 (0.59) SMN1; SMN2CASP3SENP7SENP6AHR
SCHEMBL25554227 0.81 SMN1; SMN2 (0.58) SMN1; SMN2CASP3SENP7SENP6RAB9A
SCHEMBL24545424 0.80 RCE1 (0.39) SMN1; SMN2CASP3SENP7SENP6RAB9A
SCHEMBL24547202 0.79 AHR (0.50) AHRCYP1A2CA1CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230363266-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-11-09 US disclosed
US-20230363266-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-11-09 US disclosed
WO-2022131757-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2022-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230363266-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME DRD1, OPRD1, NR1D1 SMN1; SMN2 1411/4885CASP3 3141/4885SENP7 3128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.